Employment as VP, Business Development & Alliance at a salary.
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Faheem Hasnain
Also a director
President, Chief Executive Officer and Chairman
|
67 | Not stated | $2,300,455 | |
|
Bryan Giraudo
Chief Financial Officer and Chief Operating Officer
|
51 | Not stated | $1,253,431 | |
|
Robert Smith
Chief Commercial Officer
|
57 |
Since 2023
3 years
|
$1,180,744 | |
|
Caryn Peterson
Chief Development Officer
Title from the Form 4 dated Aug 24, 2026
|
67 | Not stated | Not reported | |
|
Christian Waage
EVP, Tech Ops and Admin
Title from the Form 4 dated Aug 24, 2026
|
59 | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Sep 16, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Faheem Hasnain
Board chair, CEO
|
67 | Not stated | Not independent | None stated | Kura Oncology, Inc. | Paid as CEO | |
|
Thomas Daniel, M.D.
Lead independent director
|
72 |
2018
8 years
|
Independent |
compensation
nominating and corporate governance
|
None stated | $199,569 | |
|
Russell Cox
|
62 |
2018
8 years
|
Independent |
audit
|
None stated | $186,319 | |
|
Skye Drynan
|
50 |
2024
2 years
|
Independent | None stated | None stated | $181,444 | |
|
John Quisel, Ph.D., J.D.
|
54 |
2023
3 years
|
Independent |
audit
|
Disc Medicine, Inc. | $172,069 | |
|
Sandra Milligan, M.D., J.D.
|
62 |
2021
5 years
|
Independent |
compensation
|
Spyre Therapeutics, Inc. | $179,319 | |
|
Steven Nathan, M.D.
|
67 |
2024
2 years
|
Independent | None stated | None stated | $167,444 | |
|
Gregory A. Ciongoli
Joined Sep 16, 2026
|
- | - | Independent |
Audit Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Employment as VP, Business Development & Alliance at a salary.
Grants of 220,000 options, 45,000 RSUs and 46,875 PSUs.
Loading...